AU2003278978A1 - Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors - Google Patents
Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitorsInfo
- Publication number
- AU2003278978A1 AU2003278978A1 AU2003278978A AU2003278978A AU2003278978A1 AU 2003278978 A1 AU2003278978 A1 AU 2003278978A1 AU 2003278978 A AU2003278978 A AU 2003278978A AU 2003278978 A AU2003278978 A AU 2003278978A AU 2003278978 A1 AU2003278978 A1 AU 2003278978A1
- Authority
- AU
- Australia
- Prior art keywords
- migraine
- macrolide
- prophylactic
- therapeutic treatment
- related diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10228326.5 | 2002-06-25 | ||
| DE10228326A DE10228326A1 (en) | 2002-06-25 | 2002-06-25 | Use of macrolide and / or tetracycline compounds and / or gyrase inhibitor-containing preparations for the prophylaxis and therapeutic treatment of migraines and migraine-related diseases |
| PCT/EP2003/006703 WO2004000329A1 (en) | 2002-06-25 | 2003-06-25 | Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2003278978A8 AU2003278978A8 (en) | 2004-01-06 |
| AU2003278978A1 true AU2003278978A1 (en) | 2004-01-06 |
Family
ID=29761390
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003278978A Abandoned AU2003278978A1 (en) | 2002-06-25 | 2003-06-25 | Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU2003278978A1 (en) |
| DE (1) | DE10228326A1 (en) |
| WO (1) | WO2004000329A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2332546A1 (en) * | 2001-07-13 | 2011-06-15 | Paratek Pharmaceuticals, Inc. | Tetracyclines for the treatment of stroke |
| US12168004B2 (en) | 2014-02-05 | 2024-12-17 | Merck Sharp & Dohme Llc | Treatment of migraine |
| US12383545B1 (en) | 2018-06-08 | 2025-08-12 | Allergan Pharmaceuticals International Limited | Treatment of migraine |
| WO2022140537A1 (en) | 2020-12-22 | 2022-06-30 | Allergan Pharmaceuticals International Limited | Treatment of migraine |
| JP2024533756A (en) * | 2021-09-27 | 2024-09-12 | アラガン ファーマスーティカルズ インターナショナル リミテッド | Combination Migraine Therapies Containing Atogepant |
-
2002
- 2002-06-25 DE DE10228326A patent/DE10228326A1/en not_active Withdrawn
-
2003
- 2003-06-25 WO PCT/EP2003/006703 patent/WO2004000329A1/en not_active Ceased
- 2003-06-25 AU AU2003278978A patent/AU2003278978A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003278978A8 (en) | 2004-01-06 |
| DE10228326A1 (en) | 2004-01-22 |
| WO2004000329A1 (en) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002351397A1 (en) | Systems and methods using vasoconstriction for improved thermal treatment of tissues | |
| AU2003290548A1 (en) | Prevention and treatment of synucleinopathic disease | |
| SI1487541T1 (en) | Use of il-18 inhibitors for the treatment and/or prevention of peripheral vascular diseases | |
| AU2003291342A1 (en) | Benzotriazoles and methods of prophylaxis or treatment of metabolic-related disorders thereof | |
| AU2003229923A1 (en) | Curcumin for the prevention and/or treatment of tissue damage | |
| AU2003297460A1 (en) | TREATMENT OF OBESITY AND ASSOCIATED CONDITIONS WITH TGF-Beta INHIBITORS | |
| EP1531828A4 (en) | Methods of treating bacterial infections and diseases associated therewith | |
| AU2003291480A1 (en) | Composition for the prevention and treatment of inflammation of the ear | |
| AU2002352533A1 (en) | Methods and compositions for treatment of gastric diseases | |
| AU2003270498A1 (en) | Topical veterinary compositions and methods for the treatment and prevention of infection | |
| AU2003260778A1 (en) | Treatment of pipes | |
| AU2003270625A1 (en) | Inhibition or activation of adam9 and adam15 for treatment of vascularization-related disease and wound healing | |
| AU2003278978A1 (en) | Prophylactic and therapeutic treatment of migraine and migraine-related diseases with macrolide and/or tetracycline compounds and/or gyrase inhibitors | |
| AU2003273762A1 (en) | Use of glycogen phosphorylase inhibitors for treatment of cardiovascular diseases | |
| AU2002323106A1 (en) | Treatment and prevention of heat shock protein-associated diseases and conditions | |
| AU2003213898A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
| AU2003270815A1 (en) | Treatment of irritable bowel syndrome and related bowel diseases | |
| AU2001226609A1 (en) | Method and formulation for treatment of vasoconstriction | |
| AU2002305488A1 (en) | Combined treatments and methods of treatment of mycoplasma and mycoplasma-like organism infections | |
| AU2003216810A1 (en) | Combination ofa cdk inhibitor and 5-fu for the treatment of cancer | |
| AU2002342715A1 (en) | Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors | |
| AU2003264954A1 (en) | Pharmaceutical composition for prevention and treatment of kidney diseases | |
| AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
| AU2003208368A1 (en) | Use of sodium/hydrogen exchange inhibitors from the treatment of thrombotic and inflammatory diseases | |
| AU2003208792A1 (en) | Use of inhibitors of the sodium-dependent chloride-bicarbonate-exchanger for treating thrombotic and inflammatory diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |